If we are on our game we would be on the front foot getting in contact with Bain Capital and at least another half a dozen investors that backed Jenavalve.
They may be looking for somewhere to park a few hundred million from their realised investment.
Would be nice to have backup and an alternative to the NASDAQ, or adding some pent up demand for the IPO by investors that obviously understand the space.
In 2022 Jenavalve raised US$100m to complete their pivotal trial through these investors.
Clinical trials, page-16
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.20 |
Change
0.200(1.54%) |
Mkt cap ! $282.8M | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.50 | $13.16 | $528.4K | 39.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1024 | $13.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.20 | 209 | 1 |
View Market Depth
| Last trade - 15.47pm 12/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |